CLINICAL_TRIALS
trial_result
· 2012-01-11
Clinical Trial Update: Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN) [Phase 2]
Summary
Phase 2 safety/efficacy study comparing retigabine (ezogabine) to placebo for postherpetic neuralgia; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2012-01-11